iniparib

Sanofi Ends Cancer and Coronary Drug Trials
Motley Fool
Tue, 06/4/13 - 09:58 am
Sanofi
Otamixaban
iniparib
Sanofi Ends Iniparib Research, Plans $285 Million Charge
Bloomberg
Mon, 06/3/13 - 10:37 am
iniparib
Sanofi
lung cancer
Sanofi preps for new pivotal trial of a blockbuster hopeful
Fierce Biotech
Tue, 06/7/11 - 10:01 am
Sanofi
iniparib
breast cancer
Sanofi-Aventis' Most Promising Clinical Candidate Takes a Nasty Fall
Seeking Alpha
Sun, 01/30/11 - 12:23 pm
Sanofi
iniparib
breast cancer
Parp inhibition
BiPar breast cancer drug fails late-stage trial
bizjournals.com
Sat, 01/29/11 - 11:55 am
BiPar
breast cancer
iniparib